ENTADFI
- Product NDC
- 69681-125
- 11-digit product format
- 696810125
- Labeler code
- 69681
- Product ID
- 69681-125_e788df3c-753e-4bf8-8289-d68f4f452038
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- finasteride and tadalafil
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Veru Inc.
- Application
- NDA215423
- Marketing category
- NDA
- Marketing start
- 2021-12-12
- Marketing end
- 0000-00-00
- Substance
- FINASTERIDE; TADALAFIL
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- 5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA], Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69681-125-30 | ENTADFI | 30 in 1 BOTTLE | CAPSULE | 30 | | 2 |
| 69681-125-90 | ENTADFI | 90 in 1 BOTTLE | CAPSULE | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69681-125 | ENTADFI (FINASTERIDE AND TADALAFIL) CAPSULE [VERU INC.] | 2 | Legacy NDC, 2 package rows | 20230113_112bf653-8322-4444-8d4d-03234b11c38c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69681-125-30 | 69681012530 | 30 CAPSULE in 1 BOTTLE (69681-125-30) | 30 capsule | 2021-12-12 | 0000-00-00 | No | No | Current |
| 69681-125-90 | 69681012590 | 90 CAPSULE in 1 BOTTLE (69681-125-90) | 90 capsule | 2021-12-12 | 0000-00-00 | No | No | Current |